Low-dode aspirin wrecks the stomach or small intestine anyway in many individuals, irrespective of its form. This strikes a lot sooner than internal bleeding. Both the chewable and the enteric-coated forms cause this injury at separate locations.
So then why are we not working to determine which individuals it is suitable for?
What is the alternative to aspirin for this use case and who benefits?